Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 780

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

Open access
Bardy, Gust H., Smith, Warren M., Hood, Margaret A., Crozier, Ian G., Melton, Iain C., Jordaens, Luc, Theuns, Dominic, Park, Robert E., Wright, David J., Connelly, Derek T., Fynn, Simon P., Murgatroyd, Francis D., Sperzel, Johannes, Neuzner, Jörg, Spitzer, Stefan G., Ardashev, Andrey V., Oduro, Amo, Boersma, Lucas, Maass, Alexander H., Van Gelder, Isabelle C., Wilde, Arthur A., van Dessel, Pascal F., Knops, Reinoud E., Barr, Craig S., Lupo, Pierpaolo, Cappato, Riccardo, Grace, Andrew A.·2010·New England Journal of Medicine

Abstract

BACKGROUND: Implantable cardioverter-defibrillators (ICDs) prevent sudden death from cardiac causes in selected patients but require the use of transvenous lead systems. To eliminate the need for venous access, we designed and tested an entirely subcutaneous ICD system. METHODS: First, we conducted two short-term clinical trials to identify a suitable device configuration and assess energy requirements. We evaluated four subcutaneous ICD configurations in 78 patients who were candidates for ICD implantation and subsequently tested the best configuration in 49 additional patients to determine the subcutaneous defibrillation threshold in comparison with that of the standard transvenous ICD. Then we evaluated the long-term use of subcutaneous ICDs in a pilot study, involving 6 patients, which was followed by a trial involving 55 patients. RESULTS: The best device configuration consisted of a parasternal electrode and a left lateral thoracic pulse generator. This configuration was as effective as a transvenous ICD for terminating induced ventricular fibrillation, albeit with a significantly higher mean (+/-SD) energy requirement (36.6+/-19.8 J vs. 11.1+/-8.5 J). Among patients who received a permanent subcutaneous ICD, ventricular fibrillation was successfully detected in 100% of 137 induced episodes. Induced ventricular fibrillation was converted twice in 58 of 59 patients (98%) with the delivery of 65-J shocks in two consecutive tests. Clinically significant adverse events included two pocket infections and four lead revisions. After a mean of 10+/-1 months, the device had successfully detected and treated all 12 episodes of spontaneous, sustained ventricular tachyarrhythmia. CONCLUSIONS: In small, nonrandomized studies, an entirely subcutaneous ICD consistently detected and converted ventricular fibrillation induced during electrophysiological testing. The device also successfully detected and treated all 12 episodes of spontaneous, sustained ventricular tachyarrhythmia. (ClinicalTrials.gov numbers, NCT00399217 and NCT00853645.)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa0909545

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 780

Metadata

Authors
Bardy, G. H., Smith, W. M., Hood, M. A., Crozier, I. G., Melton, I. C., Jordaens, L., Theuns, D., Park, R. E., Wright, D. J., Connelly, D. T., Fynn, S. P., Murgatroyd, F. D., Sperzel, J., Neuzner, J., Spitzer, S. G., Ardashev, A. V., Oduro, A., Boersma, L., Maass, A. H., Van Gelder, I. C., Wilde, A. A., van Dessel, P. F., Knops, R. E., Barr, C. S., Lupo, P., Cappato, R., & Grace, A. A.
Venue
New England Journal of Medicine
Published
2010-07
Volume
363
Issue
1
Pages
36-44
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2139305230
Cited by
780
References
2
FWCI
30.86
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Entirely Subcutaneous Implantable Cardioverter–Defibrillator. https://app.cochat.ai/papers/10.1056/nejmoa0909545
The paper
Bardy, G. H., Smith, W. M., Hood, M. A., Crozier, I. G., Melton, I. C., Jordaens, L., Theuns, D., Park, R. E., Wright, D. J., Connelly, D. T., Fynn, S. P., Murgatroyd, F. D., Sperzel, J., Neuzner, J., Spitzer, S. G., Ardashev, A. V., Oduro, A., Boersma, L., Maass, A. H., . . . Grace, A. A. (2010). An Entirely Subcutaneous Implantable Cardioverter–Defibrillator. New England Journal of Medicine. https://doi.org/10.1056/nejmoa0909545

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.